Influence of immunosuppression and immunorestoration on the formation of urethan-induced lung adenomas.
Trainin
N
N
Linker-Israeli
M
M
D000236:Adenoma / Q000139:chemically induced / Q000276:immunology*; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000276:immunology*; D002273:Carcinogens; D004198:Disease Susceptibility; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000276:immunology*; D015994:Incidence; D007267:Injections; D008175:Lung Neoplasms / Q000139:chemically induced / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D013934:Thymectomy; D013950:Thymus Gland / Q000276:immunology* / Q000637:transplantation; D014185:Transplantation, Isogeneic; D014520:Urethane
D000961:Antilymphocyte Serum; D002273:Carcinogens; D007166:Immunosuppressive Agents; D014520:Urethane